Aart Geus - Synopsys Co-Founder, Chairman and Co-CEO
| SNPS Stock | USD 527.52 0.02 0% |
Chairman
Dr. Aart J. de Geus is Chairman of the Board, CoChief Executive Officer of Synopsys Inc. Dr. de Geus cofounded Synopsys and has served as Chairman of our Board of Directors since February 1998 and Chief Executive Officer since January 1994. He has served as coChief Executive Officer with Dr. ChiFoon Chan since May 2012. Since the inception of Synopsys in December 1986, Dr. de Geus has held a variety of positions, including President, Senior Vice President of Engineering and Senior Vice President of Marketing. He has served as a director since 1986, and served as Chairman of our Board from 1986 to 1992 and again from 1998 until present. Dr. de Geus has also served on the board of directors of Applied Materials, Inc. since July 2007. since 2012.
| Age | 70 |
| Tenure | 12 years |
| Professional Marks | Ph.D |
| Address | 675 Almanor Avenue, Sunnyvale, CA, United States, 94085 |
| Phone | 650-584-5000 |
| Web | https://www.synopsys.com |
Latest Insider Transactions
de Geus holds an M.S.E.E. from the Swiss Federal Institute of Technology in Lausanne, Switzerland and a Ph.D. in Electrical Engineering from Southern Methodist University.Synopsys Management Efficiency
The company has return on total asset (ROA) of 0.0875 % which means that it generated a profit of $0.0875 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.2254 %, meaning that it created $0.2254 on every $100 dollars invested by stockholders. Synopsys' management efficiency ratios could be used to measure how well Synopsys manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to gain to 0.20 in 2024, whereas Return On Capital Employed is likely to drop 0.15 in 2024. At this time, Synopsys' Fixed Asset Turnover is comparatively stable compared to the past year. Asset Turnover is likely to gain to 0.67 in 2024, whereas Deferred Long Term Asset Charges is likely to drop slightly above 313 M in 2024.Similar Executives
| Found 12 records | CHAIRMAN Age | ||
| Jay Chaudhry | Zscaler | 59 | |
| Jagtar Chaudhry | Zscaler | 65 | |
| Owen Matthews | Uipath Inc | 42 | |
| Mark McLaughlin | Palo Alto Networks | 54 | |
| Matthew Prince | Cloudflare | 48 | |
| Terence Matthews | Uipath Inc | 71 | |
| Daniel Dines | Uipath Inc | 52 | |
| John Warnock | Adobe Systems Incorporated | 83 | |
| Dheeraj Pandey | Nutanix | 43 | |
| Charles Geschke | Adobe Systems Incorporated | 78 | |
| Nikesh Arora | Palo Alto Networks | 52 | |
| Kevin Ryan | MongoDB | N/A | |
Management Performance
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0875 |
Synopsys Leadership Team
Elected by the shareholders, the Synopsys' board of directors comprises two types of representatives: Synopsys inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Synopsys. The board's role is to monitor Synopsys' management team and ensure that shareholders' interests are well served. Synopsys' inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Synopsys' outside directors are responsible for providing unbiased perspectives on the board's policies.
| Sassine Ghazi, President CEO | ||
| Shelagh Glaser, Chief Officer | ||
| Charlie Matar, Senior Group | ||
| Chrysostomos Nikias, Independent Director | ||
| Janice Chaffin, Director | ||
| John Runkel, General Counsel and Corporate Secretary | ||
| Sudhindra Kankanwadi, Principal Accounting Officer, Vice President Corporate Controller | ||
| Deirdre Hanford, Chief Officer | ||
| Antonio Varas, Chief Officer | ||
| ChiFoon Chan, President Co-CEO, Director | ||
| Michael Sanie, VP Communication | ||
| Mercedes Johnson, Independent Director | ||
| Brian Beattie, Chief Admin. Officer and Executive VP of Bus. Operations | ||
| Ann Minooka, Chief Officer | ||
| Alessandra Costa, Senior Group | ||
| Janet Collinson, HR Officer | ||
| Jason Schmitt, General Group | ||
| Raja Tabet, Senior Group | ||
| Alfred Castino, Independent Director | ||
| Deborah Coleman, Independent Director | ||
| Paul Stravers, Principal Engineer | ||
| John Koeter, Senior Strategy | ||
| Steven Walske, Lead Independent Director | ||
| Joseph Logan, Executive VP of Sales and Corporate Marketing | ||
| Trac Pham, Chief Officer | ||
| Stephen Gregorio, CFO, Executive Vice President | ||
| Bruce Chizen, Independent Director | ||
| Erika McEnroe, Senior Counsel | ||
| Aart Geus, Co-Founder, Chairman and Co-CEO | ||
| Lisa Ewbank, Vice President - Investor Relations | ||
| John Schwarz, Independent Director | ||
| Richard Mahoney, Chief Officer | ||
| Sriram Sitaraman, Senior Officer | ||
| Roy Vallee, Independent Director | ||
| Jill Larsen, Chief Officer |
Synopsys Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Synopsys a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Return On Equity | 0.23 | ||||
| Return On Asset | 0.0875 | ||||
| Profit Margin | 0.23 % | ||||
| Operating Margin | 0.22 % | ||||
| Current Valuation | 78.07 B | ||||
| Shares Outstanding | 152.54 M | ||||
| Shares Owned By Insiders | 0.40 % | ||||
| Shares Owned By Institutions | 94.34 % | ||||
| Number Of Shares Shorted | 3.44 M | ||||
| Price To Earning | 50.25 X |
Synopsys Investors Sentiment
The influence of Synopsys' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Synopsys. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Synopsys' public news can be used to forecast risks associated with an investment in Synopsys. The trend in average sentiment can be used to explain how an investor holding Synopsys can time the market purely based on public headlines and social activities around Synopsys. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Synopsys' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Synopsys' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Synopsys' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Synopsys.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Synopsys in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Synopsys' short interest history, or implied volatility extrapolated from Synopsys options trading.
Currently Active Assets on Macroaxis
When determining whether Synopsys is a strong investment it is important to analyze Synopsys' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Synopsys' future performance. For an informed investment choice regarding Synopsys Stock, refer to the following important reports:Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Synopsys. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in american community survey. For more information on how to buy Synopsys Stock please use our How to Invest in Synopsys guide.You can also try the FinTech Suite module to use AI to screen and filter profitable investment opportunities.
Complementary Tools for Synopsys Stock analysis
When running Synopsys' price analysis, check to measure Synopsys' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Synopsys is operating at the current time. Most of Synopsys' value examination focuses on studying past and present price action to predict the probability of Synopsys' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Synopsys' price. Additionally, you may evaluate how the addition of Synopsys to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Content Syndication Quickly integrate customizable finance content to your own investment portal | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Flow Index Determine momentum by analyzing Money Flow Index and other technical indicators | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum |
Is Synopsys' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Synopsys. If investors know Synopsys will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Synopsys listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth 0.651 | Earnings Share 9.07 | Revenue Per Share 40.3 | Quarterly Revenue Growth 0.211 | Return On Assets 0.0875 |
The market value of Synopsys is measured differently than its book value, which is the value of Synopsys that is recorded on the company's balance sheet. Investors also form their own opinion of Synopsys' value that differs from its market value or its book value, called intrinsic value, which is Synopsys' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Synopsys' market value can be influenced by many factors that don't directly affect Synopsys' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Synopsys' value and its price as these two are different measures arrived at by different means. Investors typically determine if Synopsys is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Synopsys' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.